Chemoinformaics analysis of 9-Methoxycanthin-6-one N-oxide
Molecular Weight | 266.256 | nRot | 1 |
Heavy Atom Molecular Weight | 256.176 | nRig | 20 |
Exact Molecular Weight | 266.069 | nRing | 4 |
Solubility: LogS | -4.82 | nHRing | 3 |
Solubility: LogP | 1.304 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 4 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 30 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 20 | No. of Aromatic Carbocycles | 1 |
nHetero | 5 | No. of Aromatic Hetero Cycles | 3 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 10 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 15 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 2 | No. of Arom Atom | 16 |
No. of Oxygen atom | 3 | No. of Arom Bond | 19 |
nHA | 4 | APOL | 36.3239 |
nHD | 0 | BPOL | 15.7841 |
QED | 0.389 |
Synth | 2.867 |
Natural Product Likeliness | 0.585 |
NR-PPAR-gamma | 0.026 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Accepted |
Pgp-inh | 0.001 |
Pgp-sub | 0.002 |
HIA | 0.006 |
CACO-2 | -4.918 |
MDCK | 0.0000326 |
BBB | 0.407 |
PPB | 0.835587 |
VDSS | 0.878 |
FU | 0.0598527 |
CYP1A2-inh | 0.941 |
CYP1A2-sub | 0.951 |
CYP2c19-inh | 0.132 |
CYP2c19-sub | 0.721 |
CYP2c9-inh | 0.016 |
CYP2c9-sub | 0.605 |
CYP2d6-inh | 0.06 |
CYP2d6-sub | 0.316 |
CYP3a4-inh | 0.015 |
CYP3a4-sub | 0.272 |
CL | 8.516 |
T12 | 0.667 |
hERG | 0.083 |
Ames | 0.983 |
ROA | 0.066 |
SkinSen | 0.076 |
Carcinogencity | 0.977 |
EI | 0.878 |
Respiratory | 0.389 |
NR-Aromatase | 0.038 |
Antiviral | Yes |
Prediction | 0.597125 |